Nicorette Microtab (Nicotine Betadex)

The nicotine in Nicorette Microtab binds to nicotinic acetylcholine receptors in the brain, especially the α4β2 subtype. This activation releases dopamine and other neurotransmitters, reproducing the rewarding effect of tobacco smoke and thereby lowering the intensity of withdrawal and craving sensations.

The appropriate dosing schedule for Nicorette Microtab is determined by a qualified healthcare professional based on the individual’s smoking history, dependence level, and treatment goals. Patients should follow the prescriber’s instructions and not alter the regimen without medical advice.

Safety data for Nicorette Microtab in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made in consultation with a physician.

To request Nicorette Microtab, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with nicotine patches or gum, Nicorette Microtab offers rapid sublingual absorption, giving quicker symptom relief. It avoids the need for chewing or wearing a patch, but like all NRTs, it should be matched to patient preference, tolerance, and the overall cessation strategy.

Store Nicorette Microtab at temperatures below 25 °C in its original packaging, protected from moisture and direct sunlight. Keep the tablets out of reach of children and do not use them after the expiry date printed on the label.

Place one tablet under the tongue and allow it to dissolve completely without chewing or swallowing whole. The tablet should remain in place for several minutes to ensure optimal sublingual absorption before swallowing any residual saliva.

Serious adverse events, although rare, include allergic reactions such as rash, swelling or breathing difficulty, chest pain, and rapid heart rate (tachycardia). Users experiencing any of these symptoms should seek immediate medical attention.

Nicorette Microtab is contraindicated in individuals with known hypersensitivity to nicotine or any tablet excipients, and in patients with recent myocardial infarction or unstable angina unless a physician explicitly advises otherwise.